45 CFR § 180 compliance
C · 70
This hospital published part of what § 180 requires.
●Machine-readable file published
○Gross / standard charges
○Discounted cash price
●Payer-specific negotiated rates
●Min / max negotiated charges
●Free, public, no login required
Procedures listed
15,803
Insurances with rates
4
CPT / HCPCS codes
11,458
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 36100961 | HC REVSC EVASC FPVT ATHRC UNI SF LES 1ST VSL | $131,101 | $98,326 | — | — | 0 |
| 36100963 | HC REVSC EVASC FPVT ATHRC UNI CPLX LES 1ST VSL | $131,101 | $98,326 | — | — | 0 |
| 36100965 | HC REVSC EVASC FPVT ST ATHRC UNI SF LES 1ST VSL | $131,101 | $98,326 | — | — | 0 |
| 36100967 | HC REVSC EVASC FPVT ST ATHRC UNI CPLX LES 1ST VSL | $131,101 | $98,326 | — | — | 0 |
| 36100962 | HC REVSC EVASC FPVT ATHRC UNI SF LES EA ADDL VSL | $98,326 | $73,744 | — | — | 0 |
| 36100964 | HC REVSC EVASC FPVT ATHRC UNI CPLX LES EA ADDL VSL | $98,326 | $73,744 | — | — | 0 |
| 36100966 | HC REVSC EVASC FPVT ST ATHRC UNI SF LES EA ADDL VSL | $98,326 | $73,744 | — | — | 0 |
| 36100968 | HC REVSC EVSC FPVT ST ATHRC UNI CPLX LES EA ADD VSL | $98,326 | $73,744 | — | — | 0 |
| 36100969 | HC INTRAVASCULAR LITHOTRIPSY FPVT W/IN SAME ARTERY | $98,326 | $73,744 | — | — | 0 |
| 214804 | ocrelizumab 30 mg/mL Soln 10 mL Vial | $86,915 | $65,186 | — | — | 0 |
| 36100947 | HC REVSC EVASC IVT ST PLMT UNI SF LES 1ST VSL UNILAT | $82,560 | $61,920 | — | — | 0 |
| 36100948 | HC REVSC EVASC IVT ST PLMT UNI SF LES 1ST VSL BILAT | $82,560 | $61,920 | — | — | 0 |
| 36100950 | HC REVSC EVASC IVT ST PLMT UNI CPLX LES 1ST VSL | $82,560 | $61,920 | — | — | 0 |
| 36100957 | HC REVSC EVASC FPVT ST PLMT UNI SF LES 1ST VSL | $82,560 | $61,920 | — | — | 0 |
| 36100959 | HC REVSC EVASC FPVT ST PLMT UNI CPLX LES 1ST VSL | $82,560 | $61,920 | — | — | 0 |
| 173998 | ecallantide 10 mg/mL (1 mL) Soln 3 mL Vial | $64,054 | $48,040 | — | — | 0 |
| 36100958 | HC REVSC EVASC FPVT ST PLMT UNI SF LES EA ADDL VSL | $61,920 | $46,440 | — | — | 0 |
| 36100960 | HC REVSC EVASC FPVT ST PLMT UNI CPLX LES EA ADD VSL | $61,920 | $46,440 | — | — | 0 |
| 174193 | ustekinumab 45 mg/0.5 mL Syrg 0.5 mL Syringe | $59,540 | $44,655 | — | — | 0 |
| 174194 | ustekinumab 90 mg/mL Syrg 1 mL Syringe | $59,540 | $44,655 | — | — | 0 |
| 231892 | risankizumab-rzaa 60 mg/mL Soln 10 mL Vial | $43,435 | $32,576 | — | — | 0 |
| 238355 | tarlatamab-dlle 10 mg Solr 1 each Vial | $42,029 | $31,522 | — | — | 0 |
| 36000037 | HC LITHOTRIPSY, BILATERAL | $39,066 | $29,299 | — | — | 0 |
| 36000038 | HC LITHOTRIPSY, UNILATERAL | $38,778 | $29,083 | — | — | 0 |
| 36100376 | HC STENT/ATH FEM-POP | $38,617 | $28,963 | — | — | 0 |
| 73690 | alteplase 100 mg Solr 1 each Vial | $35,955 | $26,966 | — | — | 0 |
| 218546 | tenecteplase 50 mg Solr 1 each Vial | $33,900 | $25,425 | — | — | 0 |
| 168112 | Panitumumab 400 mg/20 mL (20 mg/mL) Soln 20 mL Vial | $29,607 | $22,205 | — | — | 0 |
| 34400003 | HC NM QUADRMET 153M TO 150 MCI | $27,207 | $20,405 | — | — | 0 |
| 36100371 | HC STENT ILIAC INITIAL, UNILAT | $27,145 | $20,358 | — | — | 0 |
| 193605 | vedolizumab 300 mg Solr 1 each Vial | $26,237 | $19,678 | — | — | 0 |
| 800104 | ALTEPLASE INFUSION (STROKE) 100 mL Bag | $25,320 | $18,990 | — | — | 0 |
| 163213 | lanreotide 120 mg/0.5 mL Syrg 0.5 mL Syringe | $24,167 | $18,125 | — | — | 0 |
| 229515 | anifrolumab-fnia 300 mg/2 mL (150 mg/mL) Soln 2 mL Vial | $22,922 | $17,191 | — | — | 0 |
| 36100375 | HC STENT FEM-POP, UNI | $22,478 | $16,858 | — | — | 0 |
| 3611228 | HC STENT ILIAC,W W/O ATHERECTOMY,INI VES-BIL | $20,725 | $15,544 | — | — | 0 |
| 27205794 | HC M ATHERECTOMY DEVICE | $20,596 | $15,447 | — | — | 0 |
| 36100378 | HC ATHERECT TIB-PER INITIAL | $20,366 | $15,275 | — | — | 0 |
| 36100466 | HC ATHERECTOMY FEM-POP | $20,366 | $15,275 | — | — | 0 |
| 36100637 | HC EMBO ART/VENO HEMORRHAGE | $19,758 | $14,819 | — | — | 0 |
| 74755 | digoxin immune fab 40 mg Solr 1 each Vial | $19,431 | $14,573 | — | — | 0 |
| 201195 | pegfilgrastim 6 mg/0.6 mL Syin 0.6 mL Syringe | $18,945 | $14,209 | — | — | 0 |
| 76864 | pegfilgrastim 6 mg/0.6mL Syrg 0.6 mL Syringe | $18,945 | $14,209 | — | — | 0 |
| 36100366 | HC PTA TIB-PER EA ADDL | $18,613 | $13,960 | — | — | 0 |
| 36100370 | HC PTA ILIAC INITIAL | $18,613 | $13,960 | — | — | 0 |
| 36100377 | HC PTA TIB-PER INITIAL | $18,613 | $13,960 | — | — | 0 |
| 36100639 | HC EMBO TUMOR/ORGAN | $16,938 | $12,704 | — | — | 0 |
| 36100578 | RC IR VERTEBRAL BILAT SELECT SUBCL | $16,625 | $12,469 | — | — | 0 |
| 36100566 | HC CEREBRAL UNILAT SELECT INTERN | $16,537 | $12,403 | — | — | 0 |
| 36100568 | HC VERTEBRAL UNILAT SELECT VERT | $16,537 | $12,403 | — | — | 0 |
Showing top 50 of 15,803 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.